Perlmutter Cancer Center, NYU Langone Health, New York — New York, New York

Perlmutter Cancer Center, NYU Langone Health, New York is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center, NYU Langone Health, New York has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer.

Sponsors: Invitae Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center, NYU Langone Health, New York?

Perlmutter Cancer Center, NYU Langone Health, New York has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center, NYU Langone Health, New York conducted?

Perlmutter Cancer Center, NYU Langone Health, New York has 1 clinical trials on record. Their work covers Prostate Cancer.

Is Perlmutter Cancer Center, NYU Langone Health, New York accredited by Crixeo Health?

Perlmutter Cancer Center, NYU Langone Health, New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center, NYU Langone Health, New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.